![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print April 30, 2002
Institute of Immunology, Vienna A-1090
Corresponding Author: gerhard.zlabinger{at}univie.ac.at
The transcription factor NF-AT plays an essential role in the activation of many early immune response genes. A dynamic equilibrium between calcineurin and cellular kinases controls its phosphorylation and thus regulates its activity by determining its subcellular localization. Here, we demonstrate that T-cell activation in the presence of the bacterial metabolite n-butyrate which leads to inhibition of IL-2 transcription is characterized by the maintenance of the activity of counter-regulatory kinases glycogen synthase kinase 3 and protein kinase A as well as persistence of intracellular cAMP levels, while calcium response and mitogen-activated protein kinase activation were indistinguishable from cells stimulated in the absence of n-butyrate. Nuclear binding of NF-AT was decreased but other transcription factors implicated in IL-2 expression such as AP1 and NFkB were unaffected. The effect on NF-AT binding appeared to be due to increased nuclear export since the export inhibitor leptomycin B completely restored nuclear binding of NF-AT. We, therefore, provide first evidence for interference with NF-AT regulation alternative to the currently understood inhibition of nuclear import. This mechanism might represent a bacterial strategy to subvert host defense which could be of particular clinical importance in the gastrointestinal tract where high amounts of n-butyrate are physiologically present.
J. Biol. Chem, 10.1074/jbc.M200191200
Submitted on January 8, 2002
Revised on April 8, 2002
Accepted on April 29, 2002
Novel mode of interference with NF-AT regulation in T-cells by the bacterial metabolite n-butyrate
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Bosisio, M. Vulcano, A. Del Prete, M. Sironi, V. Salvi, L. Salogni, E. Riboldi, F. Leoni, C. A. Dinarello, G. Girolomoni, et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo J. Leukoc. Biol., December 1, 2008; 84(6): 1540 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nakamura, I. Matsushita, E. Kosaka, T. Kondo, and T. Kimura Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells Rheumatology, April 1, 2008; 47(4): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, T. Kukita, T. Shobuike, K. Nagata, Z. Wu, K. Ogawa, T. Hotokebuchi, O. Kohashi, and A. Kukita Inhibition of Histone Deacetylase Suppresses Osteoclastogenesis and Bone Destruction by Inducing IFN-{beta} Production J. Immunol., November 1, 2005; 175(9): 5809 - 5816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |